ANO9-DEAF1 Fusion FISH Probe
The ANO9-DEAF1 Fusion FISH Probe is used to confirm a fusion of the ANO9 and DEAF1 genes. The fusion of the ANO9 and DEAF1 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ANO9-DEAF1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ANO9-DEAF1-20-AQAQ | 20 (40 μL) | 200 μL |
|
DEAF1 Gene Summary
This gene encodes a zinc finger domain-containing protein that functions as a regulator of transcription. The encoded proteins binds to its own promoter as well as to that of several target genes. Activity of this protein is important in the regulation of embryonic development. Mutations in this gene have been found in individuals with autosomal dominant cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Gene Name: DEAF1, Transcription Factor
Chromosome: CHR11: 644224 -695740
Locus: 11p15.5
ANO9 Gene Summary
The protein encoded by this gene is a member of the TMEM16 (anoctamin) family of proteins, some of which form integral membrane calcium-activated chloride channels. The function of the encoded protein has yet to be elucidated, although it may have channel-forming abilities and also may have phospholipid scramblase activity. This gene has been observed to be upregulated in stage II and III colorectal cancers. [provided by RefSeq, Dec 2016]
Gene Name: Anoctamin 9
Chromosome: CHR11: 417929 -442011
Locus: 11p15.5
Gene Diseases
The ANO9 DEAF1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|